Product, manufacturer, study and quantity pre-check
Confirm intended use, study role and parties. Client-facing output: Application checklist.
Clinical trial logistics
Import License We provide import license submission procedures to MoH. Our depot is also 8 km (5 miles) to MoH. With these location advantage, we…
Permit readiness
Confirm intended use, study role and parties. Client-facing output: Application checklist.
Compare protocol, approval, product, manufacturer and quantity. Client-facing output: Submission record.
Identify missing or conflicting documents before booking. Client-facing output: Permit or outcome document.
Compile controlled versions and authorisations. Client-facing output: Shipment-readiness notice.
Client-anonymized operating experience
Client names remain private; vaccine studies are shown by name with their own project figures.
International routes · Urgent coordination
Project scope6 routes · 28–35 hours from origin to destination
Past shipment summaries originating in New Delhi, London, Beijing, New York, Hong Kong and Shanghai cover cell-therapy material, research medicines, kits and consumables. The recorded times run from origin to destination; they are not customs-clearance durations.
For sponsors: For an urgent request, share product class, permit status, origin and target delivery time on one timeline.
Customs coordinationSource: past project summaries supplied by Omega. Quantities and times describe only the relevant historical examples, not current capacity or a delivery commitment. The source does not distinguish vaccine doses from vials.
Short answer
Import licensing aligns approved study data with product, manufacturer, quantity and shipment documents before entry into Türkiye.
Procurement brief
Import licensing connects the approved study and product data to the shipment dossier.
RACI
Exception scenarios
Hold dispatch while the sponsor assesses an amendment or new application.
Recheck affected fields and reconcile the dossier.
Do not guarantee timing; document dependencies and risks.
Operating model
Every project follows the same control logic, adapted to product and protocol requirements.
Confirm intended use, study role and parties.
Compare protocol, approval, product, manufacturer and quantity.
Identify missing or conflicting documents before booking.
Compile controlled versions and authorisations.
Assign authority questions to the correct owner.
Reconcile the outcome against invoice, packing and transport data.
Service-specific FAQ
A provisional booking may be possible, but movement should not be confirmed before permission and shipment data reconcile.
Review wording, quantity, product and validity; never assume automatic reuse.
Yes. Manufacturer identity is a core approval and application field.
Omega coordinates the operational dossier; it does not author sponsor or manufacturer scientific evidence.
A project schedule follows review of completeness, scope, authority questions and likely changes.
Inside the facility
Omega Depot
Share the product, route and timeline; our team will map a workable operational flow.